Gujarat Themis Biosyn postal ballot backs 2 plans 2026

Shareholders approve wider financial powers

Gujarat Themis Biosyn Limited informed stock exchanges that shareholders have approved two special resolutions through a postal ballot conducted via remote e-voting. The approvals expand the company’s ability to raise borrowings and to undertake inter-corporate financial activities such as loans, guarantees and investments. The e-voting results were scrutinised by a company secretary, and both resolutions received near-unanimous support. The company described the outcome as enabling critical financial and operational decisions. The disclosures were part of a sequence of regulatory updates filed with exchanges during late March and early April 2026, and later updates tied to the May to June 2026 voting window.

What was approved in the June 2026 outcome

The first special resolution relates to increasing borrowing limits and allowing the company to create a mortgage or charge on assets, properties or undertakings. This falls under Section 180(1)(c) and Section 180(1)(a) of the Companies Act, 2013, as described in the postal ballot notice. The second special resolution authorises the company to give loans, provide guarantees, make investments, provide security for loans, and acquire securities beyond thresholds set in Section 186 of the Companies Act, 2013. Together, these approvals widen the company’s options to finance operations and to support eligible entities through permitted inter-corporate arrangements. The company stated the resolutions were passed via postal ballot.

Voting numbers show strong support

The reported voting results show approval levels above 98% for both items. For Resolution 1, 79,353,828 votes were cast, with 78,075,799 votes in favour, translating to 98.39% support. For Resolution 2, 79,358,328 votes were cast, with 78,074,514 votes in favour, translating to 98.38% support. The results were based on remote e-voting, and the scrutiny was completed before the outcome was published.

What changes now for Gujarat Themis Biosyn

With shareholder approval in place, Gujarat Themis Biosyn now has the mandate to secure additional debt and, if needed, leverage assets as collateral within the scope of the approved resolution. The Section 186 approval also provides the corporate authorisation to extend loans, give guarantees, and make investments, subject to the company’s internal policies and the legal framework. In practical terms, the mandate can support funding flexibility and inter-corporate financial support for eligible subsidiaries, joint ventures, or other permitted counterparties. The company’s update framed the approvals as strengthening financial and operational decision-making capacity.

How the postal ballot process was structured

The company disclosed that it engaged Central Depository Services (India) Limited (CDSL) to provide the remote e-voting facility. Voting was conducted exclusively through electronic means, with no physical postal ballot forms distributed. Voting rights were to be calculated based on the paid-up value of equity shares registered as of the applicable cut-off date mentioned in the notice. The company also indicated that the results would be published along with the scrutiniser’s report on the company website and the CDSL portal, and then forwarded to the BSE and NSE.

Timeline: two separate e-voting windows disclosed

In its exchange filings and reproduced notices, Gujarat Themis Biosyn disclosed more than one postal ballot timeline in 2026. One notice references an e-voting window from 19 March 2026 (9:00 a.m. IST) to 17 April 2026 (5:00 p.m. IST), with results to be declared latest by 21 April 2026, and a cut-off date of 13 March 2026. Another notice for the financial-operational resolutions specifies an e-voting window from 6 May 2026 (9:00 a.m. IST) to 4 June 2026 (5:00 p.m. IST), with results to be announced latest by 8 June 2026, and a cut-off date of 1 May 2026. These timelines were disclosed as part of compliance-driven filings and postal ballot communications.

Earlier postal ballot items disclosed in March 2026 notice

Separately, the March 2026 postal ballot notice publication referenced two items for shareholder consideration through remote e-voting. The first was the proposed re-appointment of Mrs. Kirandeept Madan (DIN: 00686547) as Non-Executive Woman Independent Director for a second term of five consecutive years. The notice stated her then-current term was from 1 May 2021 to 30 April 2026, and the proposed term was from 1 May 2026 to 30 April 2031. The disclosure stated remuneration for FY 2025-26 at ₹0.088 crore and recorded attendance at 7 board meetings. The second item was approval for material related party transactions with Themis Medicare Limited (TML) for an aggregate value of ₹50 crore during FY 2026-27, with TML described as a promoter group entity holding 23.19% of Gujarat Themis Biosyn’s equity share capital.

Compliance trail: SEBI and MCA references

The company stated it published the postal ballot notice in newspapers as required under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and referenced Regulation 30 for disclosure to exchanges. The filings note that, in line with Ministry of Corporate Affairs (MCA) circulars, no physical copies of the notice were dispatched and voting was permitted only through remote e-voting. The company said the postal ballot notice and explanatory statements were made available on the company website and also on the websites of BSE, NSE, and CDSL. For e-voting-related grievances, the notice provided a point of contact at CDSL.

Market impact: what investors should take from the filings

The immediate market-relevant takeaway from the outcome is the high level of shareholder support for management’s request to broaden financing and inter-corporate activity powers. Borrowing and asset-charge authorisations can be important when companies want headroom for debt, working capital facilities, or other funding arrangements that may require security creation. Similarly, Section 186 approvals matter for companies that may need flexibility to provide guarantees or invest in other entities within permitted limits and governance processes. At the same time, the filings also underline a compliance-led approach, including newspaper publication under SEBI rules and electronic-only voting under MCA circulars.

Conclusion

Gujarat Themis Biosyn’s postal ballot outcome shows strong shareholder backing for expanded borrowing authority and for loans, guarantees and investments under the Companies Act. The company has also disclosed detailed compliance steps, including e-voting through CDSL and newspaper publication under SEBI LODR rules. Going forward, investors will track how the company uses the newly approved headroom and the timelines for publishing outcomes and scrutiniser reports as outlined in the notices.